All the latest articles & insight from our investment writers to inspire your own research and analysis.
There’s no harm in using fund managers as a source for investment ideas but blindly copying them without doing your own research can be a costly mistake. Phil looks at the recent purchase of Rightmove shares by two well-known professional investors to see if private investors should consider buying in as well. Why copying others
This week, Jamie Ward talks about why missing out on some great investments might not be a bad thing, especially when thinking of the wider context where you may have invested in something better. He believes that having a process is far more important than whether you did or did not buy a security and
This week we have Stock Whittler and Sue from East Anglia kindly sharing a bit about their investing journey and how they use ShareScope.
In the last update, I looked at the leading markets (NASDAQ & S&P500) and what to expect after the break higher and I also talked about the AI stocks becoming frothy. Can anyone remember AI? So, What Happened? The leading markets melted around 5% higher over the coming weeks and then ran out of steam
Richard uses SharePad and Artificial Intelligence to help him learn about listed law firms. The legal sector is not quite the unappreciated stock market backwater he anticipated. It is a bit of a horror show, with a couple of light intermissions. It was the data that alerted me to the opportunity in listed law firms.
This week, Jamie Ward returns to talk about how passive investing is logical but isn’t really investing. He also posits that passive investment cannot exist without active investment but the reverse is not true. Companies covered: DCC, OCN. US inflation data set the tone for markets last week. The previous readings for US core and
Judges Scientific has delivered mega-bagger returns for its very early shareholders. Maynard Paton studies the growth and success of the ‘buy and build’ operator. Today’s rough market for small-cap shares could be the exact time to hunt for your next great portfolio winner. Take Judges Scientific, the £540 million group of scientific instrument manufacturers, which
Profit warnings are part and parcel of the experience of owning shares. They are not pleasant but they often contain valuable lessons which can benefit investors in the future. Sometimes they can just reflect a temporary blip. But they can also be a reason to question the sustainability of a company’s strategy and business model.
While away on an Australian retreat, Bruce asked ex-fund manager and private investor Jamie Ward to manage his weekly commentary for the upcoming weeks. Jamie takes a look into Diego DGE, Beazley BEZ and The Works WRKS. Markets had a poor end to an otherwise rather uneventful week. This resulted in equity markets being down
Michael looks at staggering stops and position weights to increase the likelihood of profit on the trade. Many regular readers will know I’m a fan of staggering stops in volatile markets. The beauty of staggering stops is that by splitting the position into mini positions, you can widen part of your stop without taking on
It has been a month since Richard revealed the latest shares to pass his 5 Strikes system. The good news, some have passed with flying colours. 5 Strikes* is my main method of discovering new long-term investments, and since we share my discoveries here regularly, some readers will be familiar with it by now. If
With two more bids coming in for small-cap stocks, Bruce looks at the average premiums being offered by buyers. Companies covered: AML, ULTP and HEIQ. The FTSE 100 was up +1.3% to 7,426 last week. Meanwhile, there was a very strong rally in the US markets with Nasdaq100 +6.4% and the S&P500 up +5.9%.
